IBD & Intestinal Disorders
From the AGA Journals
Two-thirds with microscopic colitis respond to bile acid sequestrants
Treatment may resolve chronic diarrhea in some patients with microscopic colitis.
From the AGA Journals
Low-certainty evidence supports probiotics for IBS
Some combinations of probiotics or strains may be beneficial in IBS, but the evidence for efficacy is poor.
News from the FDA/CDC
FDA OKs subcutaneous vedolizumab for UC maintenance therapy
The safety profile of subcutaneous vedolizumab was “generally consistent” with the intravenous form of the drug, with the addition of injection-...
From the Journals
ChatGPT may aid decision-making in the ED for acute ulcerative colitis
Chatbot provided a detailed answer depicting severity of every variable of the criteria and an overall severity classification.
From the Journals
Many young people stop ulcerative colitis maintenance treatment, risking relapse
Globally, the incidence of UC is increasing fastest in younger populations. It’s estimated that up to 30% of individuals with UC are diagnosed in...
Article
Digital Tools in the Management of IBS/Functional GI Disorders
Article
The Evolving Role of Surgery for IBD
Supplements
Gastroenterology Data Trends 2023
From the AGA Journals
Rectal cancer risk is markedly higher at 10 years post colectomy
Study findings suggest that more intensive long-term surveillance is needed for colectomized patients with IBD.
From the AGA Journals
AGA CPU: Essentials to prevent complications with ostomies
Multidisciplinary coordination is imperative to prevent hospital readmissions and improve quality of life for patients.